Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Pan Afr Med J ; 47: 56, 2024.
Article in English | MEDLINE | ID: mdl-38646132

ABSTRACT

Introduction: the laboratory diagnosis of meningococcal meningitis relies on conventional techniques. This study aims to evaluate the correlation between the reduced sensitivity to penicillin G of Neisseria meningitidis (N.m) strains and the expression of the altered PBP 2 gene. Methods: out of 190 strains of N.m isolated between 2010 and 2021 at the bacteriology laboratories of Ibn Rochd University Hospital Centre (IR-UHC) in Casablanca and the UHC Mohammed VI in Marrakech, 23 isolates were part of our study. We first determined their state of sensitivity to penicillin G by E-Test strips and searched for the expression of the penA gene by PCR followed by Sanger sequencing. Results: of all the confirmed cases of N.m, 93.15% (n=177) are of serogroup B, 75.2% (n = 143) are sensitive to penicillin G and 24.73% (n = 47) are of intermediate sensitivity. No resistance to penicillin G was observed. Reduced sensitivity to penicillin G in N.m is characterized by mutations namely F504 L, A510 V, I515 V, G541 N and I566 V located in the C-terminal region of the penA gene encoding the penicillin-binding protein 2 (PBP2) (mosaic gene). Conclusion: our study presents useful data for the phenotypic and genotypic monitoring of resistance to penicillin G in N.m and can contribute to the analysis of genetic exchanges between different Neisseria species.


Subject(s)
Anti-Bacterial Agents , Hospitals, University , Meningitis, Meningococcal , Microbial Sensitivity Tests , Neisseria meningitidis , Penicillin G , Morocco , Humans , Anti-Bacterial Agents/pharmacology , Neisseria meningitidis/genetics , Neisseria meningitidis/drug effects , Neisseria meningitidis/isolation & purification , Penicillin G/pharmacology , Meningitis, Meningococcal/microbiology , Meningitis, Meningococcal/drug therapy , Polymerase Chain Reaction , Mutation , Penicillin-Binding Proteins/genetics , Bacterial Proteins/genetics , Penicillin Resistance/genetics , Drug Resistance, Bacterial/genetics , Neisseria meningitidis, Serogroup B/genetics , Neisseria meningitidis, Serogroup B/isolation & purification , Neisseria meningitidis, Serogroup B/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...